MOTS-C Purity: What 99% Actually Means on a COA

Evaluating a MOTS-C purity COA requires analyzing both chromatography area percentage and net peptide content. PX1 Research delivers verified, high-purity research peptides backed by lot-matched HPLC/MS and endotoxin testing, transparent batch traceability, USA-based synthesis, and same-day dispatch (M–F before 2 PM PST) from California and Arizona facilities.

GMP-compliant U.S. facilities
ISO 17025 third-party COAs
100% domestic — no imports
Fast tracked domestic shipping
Shop research peptides

Quick answer

Evaluating a MOTS-C purity COA requires analyzing both chromatography area percentage and net peptide content. PX1 Research delivers verified, high-purity research peptides backed by lot-matched HPLC/MS and endotoxin testing, transparent batch traceability, USA-based synthesis, and same-day dispatch (M–F before 2 PM PST) from California and Arizona facilities.

Reviewed by PX1 Research scientific team

Key takeaways

  • A 99% purity claim on a [Certificate of Analysis](/research-peptides/what-is-a-coa-for-peptides) (COA) for [MOTS-c](/research-peptides/mots-c) indicates high chromatographic purity via reverse-phase high-performance liquid chromatography (RP-HPLC), but it does not represent net peptide content.
  • [MOTS-c](/research-peptides/mots-c) (mitochondrial open reading frame of the 12S rRNA type-c) is a 16-amino-acid mitochondrial-derived peptide.
  • The most common misinterpretation on a peptide COA occurs between chromatographic purity (RP-HPLC area percentage) and net peptide content.
  • While RP-HPLC establishes chemical homogeneity, it cannot confirm structural identity on its own.

The short version

A 99% purity claim on a Certificate of Analysis (COA) for MOTS-c indicates high chromatographic purity via reverse-phase high-performance liquid chromatography (RP-HPLC), but it does not represent net peptide content. Lyophilized peptide preparations naturally contain counterions such as trifluoroacetate (TFA) and residual moisture, meaning 10 mg of raw powder typically yields 7.5 to 8.5 mg of active peptide mass.

A rigorous COA must combine RP-HPLC purity, mass spectrometry (MS) mass identification, counterion analysis, and Limulus Amebocyte Lysate (LAL) endotoxin testing. Researchers looking to order analytical-grade MOTS-c must demand lot-matched, third-party analytics to ensure experimental reproducibility across in vitro and preclinical models.

What is MOTS-c and why does purity matter in preclinical research?

MOTS-c (mitochondrial open reading frame of the 12S rRNA type-c) is a 16-amino-acid mitochondrial-derived peptide. As an endogenous signaling molecule, MOTS-c is widely investigated for mitochondrial function, metabolic regulation, and exercise-capacity research. In cellular and animal models, the **mots c peptide** translocates to the nucleus under metabolic stress to modulate nuclear gene expression, glucose homeostasis, and fatty acid oxidation pathways.

Because mitochondrial signaling pathways respond dynamically to micromolar changes in peptide concentration, chemical impurities or endotoxin contamination in synthetic **motsc** batches can yield confounding experimental artifacts. Unintended sequence truncations, organophilic solvents, or trace heavy metals can trigger non-specific inflammatory pathways or cellular toxicity, corrupting baseline bioenergetic data. Obtaining a verified **mots-c purity coa** is the primary safeguard against baseline experimental distortion.

RP-HPLC area percent vs. net peptide content: The primary COA confusion

The most common misinterpretation on a peptide COA occurs between chromatographic purity (RP-HPLC area percentage) and net peptide content. Reverse-phase high-performance liquid chromatography separates peptide species based on hydrophobicity, calculating purity by integrating the UV absorbance peak area of the target peptide relative to total integrated peak area at 214 nm or 220 nm. A report indicating 99.1% RP-HPLC purity simply means that of the peptide material present in the sample, 99.1% matches the primary target sequence.

However, RP-HPLC area percent does not measure total non-peptide mass in the vial. Freshly synthesized lyophilized peptides retain non-peptide weight in the form of trifluoroacetic acid (TFA) salt counterions and residual water. Consequently, a 10 mg vial of 99% HPLC-pure MOTS-c may contain only 8.0 mg of active peptide sequence, with the remaining 2.0 mg consisting of TFA salts and moisture. Laboratories conducting precise molar calculations must adjust stock reconstitutions based on net peptide content or quantitative amino acid analysis (AAA) rather than reliance on gross lyophilisate weight alone.

Mass spectrometry (ESI-MS): Verifying the molecular identity of MOTS-c

While RP-HPLC establishes chemical homogeneity, it cannot confirm structural identity on its own. A closely related sequence variant or an isomer with identical hydrophobic retention behavior could potentially co-elute with the target peak under standard chromatography conditions. Electrospray Ionization Mass Spectrometry (ESI-MS) or Matrix-Assisted Laser Desorption/Ionization (MALDI-TOF) is required to verify exact molecular mass.

The theoretical molecular weight of MOTS-c must match the observed mass-to-charge (m/z) ratios on the mass spectrum. A valid COA features clear mass spectra displaying multi-charged ion states that unambiguously calculate to the predicted molecular mass of the primary sequence. When reviewing vendor documentation, confirm that the mass spec readout corresponds specifically to your lot number rather than a standardized template image.

TFA salt content and residual moisture: How hidden mass inflates apparent purity

During solid-phase peptide synthesis (SPPS), cleavage from the resin matrix and subsequent RP-HPLC purification utilize mobile phases containing trifluoroacetic acid. As a result, basic amino acid residues (such as arginine and lysine) form TFA salts. Unless a secondary ion-exchange chromatography step is performed to convert the peptide to an acetate or hydrochloride salt form, TFA remains bound to the structure.

In standard lyophilized research peptides, TFA can account for 10% to 15% of total mass, while residual moisture accounts for another 3% to 8%. Vendor literature claiming '99% pure peptide' based solely on HPLC area percentage conceals this distinction. When conducting sensitive metabolic regulation assays, variable TFA concentrations can impact cellular pH and alter baseline cellular respiration rates. Researchers preparing precision protocols should audit both TFA counterion levels and water content (determined via Karl Fischer titration) or utilize suppliers offering detailed compositional transparency.

Bacterial endotoxins and LAL assay testing: Why purity alone is not enough

High chemical purity does not guarantee biological suitability. Bacterial endotoxins—lipopolysaccharides (LPS) derived from Gram-negative bacterial cell walls—are common contaminants introduced during synthesis, purification, or lyophilization processes. In cellular assays, even trace endotoxin concentrations (>0.1 EU/mg) can activate Toll-like receptor 4 (TLR4) pathways, causing inflammatory cytokine release that completely masks or mimics metabolic signaling pathways.

To guarantee research integrity, MOTS-c batches must undergo quantitative Limulus Amebocyte Lysate (LAL) testing or recombinant Factor C (rFC) assays. A comprehensive COA must explicitly declare endotoxin levels, ideally below 0.05 EU/mg or 0.1 EU/mg. Relying on material without verified endotoxin metrics risks introducing uncontrolled variables into mitochondrial function and exercise-capacity research models.

How two vendors can claim 99% purity for MOTS-c and deliver vastly different products

Two suppliers offering '99% pure MOTS-c' can supply material with dramatically different physical compositions and biological behavior. Vendor A may perform an internal HPLC run under non-optimized column conditions, yielding a single compressed peak that hides minor deletion sequences, while ignoring TFA content and endotoxin levels entirely.

In contrast, Vendor B utilizes an independent ISO/IEC 17025 accredited laboratory to run high-resolution gradient RP-HPLC, ESI-MS mass verification, Karl Fischer moisture titration, and LAL endotoxin quantification. While both vendors market '99% purity' on their product cards, Vendor A provides a vial containing 78% active peptide by mass contaminated with 5.0 EU/mg endotoxins, whereas Vendor B delivers verified sequence purity with known net peptide concentration and strict endotoxin limits.

Supplier vetting framework: Vendor comparison criteria

To evaluate peptide vendors objectively prior to institutional procurement, compare suppliers across six critical operational criteria:

• Purity Verification Method: High-resolution gradient RP-HPLC with full integration tables covering all peaks, not cropped chromatograms. • Molecular Identity Confirmation: Multi-charged ESI-MS or MALDI-TOF mass spectra matching calculated theoretical molecular weight. • Endotoxin Quantification: Lot-specific LAL assay data with defined limits (<= 0.1 EU/mg) rather than generic 'pass' statements. • Net Peptide Content Traceability: Reporting on counterion content (TFA) and residual moisture (Karl Fischer titration). • Sourcing & Batch Integrity: USA-based synthesis or domestic quality assurance re-testing with batch-specific lot tracking. • Logistics & Bulk Scaling: Cold-chain management and rapid dispatch with options for bulk peptide ordering for larger study cohorts.

Red flags when auditing a MOTS-c certificate of analysis

When reviewing documentation prior to purchase, inspect the COA for these common warning signs:

1. Photocopied or Generic COAs: Documents lacking dynamic lot numbers, run dates, or matching batch IDs on the physical vial label. 2. Cropped Chromatograms: HPLC graphs that hide early-eluting solvent fronts or late-eluting impurities by truncating the baseline or time axes. 3. Absence of Mass Spectrometry Data: Purity claims backed only by HPLC, leaving open the risk of structural sequence errors or amino acid deletions. 4. Missing Testing Laboratory Information: COAs generated internally without third-party verification or accredited testing facility signatures. 5. Omission of Endotoxin Reporting: Total absence of LAL testing data on peptides intended for cell culture or preclinical animal models.

How to request and verify a lot-matched COA for your lab

Principal investigators and lab procurement personnel should establish a standardized verification protocol for every incoming shipment. Always request a lot-matched certificate directly from the vendor prior to buffer reconstitution. Cross-reference the batch control number printed on the vial label against the analytical report headers.

To verify authenticity, cross-check batch records via an online COA database or contact the third-party testing facility named on the COA to confirm report issuance. Check that the HPLC run conditions (column stationary phase, mobile phase gradient, UV detection wavelength) are clearly stated. If you plan to purchase 10 mg MOTS-c vials for long-term experimental series, request batch-reservation options to maintain lot continuity across your study protocol. Explore our broader catalog of research peptides for complementary compounds tested under identical analytical standards.

Related mitochondrial research peptides

Mitochondrial bioenergetics research frequently examines MOTS-c alongside other targeted peptide structures. Investigators studying mitochondrial membrane dynamics and metabolic pathways often compare or combine experimental designs using compounds such as:

SS-31 mitochondrial peptide: Investigated for cardiolipin targeting and mitochondrial inner membrane stabilization. • NAD+ research formulations: Evaluated in cellular energy metabolism, sirtuin activation, and redox state studies. • Mitochondrial peptide research guides: Technical documentation detailing secondary structure, reconstitution stability, and handling protocols across mitochondrial signaling agents.

Ordering from PX1 Research

PX1 Research provides institutional-grade research peptides synthesized and verified under strict analytical controls. Every lot of MOTS-c is dispatched as a vacuum-sealed lyophilized cake in sterile glass vials designed to maintain compound stability.

What Ships: Premium lyophilized MOTS-c in 5 mg or 10 mg flip-top glass vials, securely packaged with lot-specific QR codes linking directly to third-party analytical documentation. Quality Assurance: Every batch includes individual lot-matched HPLC chromatograms, ESI-MS spectrum reports, Karl Fischer water titration data, and LAL endotoxin testing (<= 0.05 EU/mg). Fulfillment & Dispatch: Orders placed before 2:00 PM PST Monday through Friday ship same-day from our dual dispatch hubs in California and Arizona via tracked express domestic transit. Technical Support: Our dedicated USA-based analytical support team is available to assist lab personnel with COA interpretation, batch reservation, and reconstitution inquiries. Ready to secure analytical-grade peptides for your lab? You can buy high-purity MOTS-c for research directly from PX1 Research or consult our technical staff for institutional purchasing options.

Frequently Asked Questions

Is MOTS-c legal to buy in the US for research?

Yes, MOTS-c is fully legal to purchase across the United States as a laboratory research chemical. It is strictly designated for in vitro and preclinical laboratory research and is not approved for human consumption, clinical use, or therapeutic administration.

How do I interpret the HPLC graph on a MOTS-c COA?

The HPLC chromatogram displays peak area absorbance over time. Look for a dominant single peak matching the target retention time. The area percentage is calculated by dividing the main peak area by the sum of all integrated peak areas, indicating sequence purity relative to other organic components.

What is the difference between 98% and 99% MOTS-c purity?

A 1% difference in HPLC purity represents a lower concentration of deletion sequences or synthetic side-products. Lower purity levels can introduce variable levels of sequence truncations that alter baseline biological responses in sensitive cellular assays.

Does PX1 Research provide a lot-matched COA for my shipment?

Yes, PX1 Research includes a lot-specific Certificate of Analysis with every shipment. Each vial features a lot control code that links directly to third-party HPLC, ESI-MS, and LAL endotoxin testing data generated for that exact batch.

What purity level should I require for mitochondrial function research?

For mitochondrial signaling, metabolic regulation, and cell culture studies, researchers should specify >= 98% HPLC purity with verified low endotoxin levels (< 0.1 EU/mg) to avoid non-specific inflammatory pathways triggered by bacterial contaminants.

Why does net peptide mass differ from gross lyophilized powder weight?

Lyophilized peptide cakes contain counterions (such as TFA) and residual moisture bound to the peptide structure during manufacturing. Consequently, 10 mg of total powder typically contains 7.5 to 8.5 mg of net active peptide sequence.

How fast does PX1 ship MOTS-c orders?

PX1 Research dispatches orders same-day Monday through Friday when placed before 2:00 PM PST. Shipments originate from strategic facilities in California and Arizona with full domestic tracking.

How should MOTS-c lyophilized powder be stored upon receipt?

Upon receipt, store lyophilized MOTS-c vials at -20°C or -80°C in a dry, dark environment. Avoid repeated freeze-thaw cycles and reconstitute only immediately prior to experimental protocols using sterile, buffer-matched solvents.

Related pages

All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.